Trial NCT04463264
Publication Silva M, medRxiv, 2021
Primary outcome on the report: Viral eradication from the patients’ respiratory tract secretions on day 7 after starting treatment (a viral eradication of at least 35% would be clinically relevant).

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.